---
title: "Merz Pharmaceuticals LLC and others v Viatris Santé (UPC CoA 917/2025, 26-01-2026)"
description: "The Court of Appeal declined to decide, for now, Merz's request under R 262.2 RoP to keep a new exhibit away from the public."
url: https://pitch.law/academy/upc-court-of-appeal/upc-coa-917-2025-2026-01-26
lang: en
author: "UPC Case Law by Pitch"
editor: "Bart Lieben"
datePublished: 2026-11-18T10:07:28.153Z
dateModified: 2026-11-18T10:07:28.153Z
---

# Merz Pharmaceuticals LLC and others v Viatris Santé

Order of the UPC Court of Appeal of 26 January 2026, UPC CoA 917/2025.

UPC Case Law by Pitch, edited by [Bart Lieben](https://pitch.law/team/bart-lieben) · Published 18-11-2026

## TL;DR

The Court of Appeal declined to decide, for now, Merz's request under R 262.2 RoP to keep a new exhibit away from the public. It also held that a party cannot block the opposing party's access to a document merely by uploading it as "highly confidential" (HC). Protection against the other side requires a R 262A RoP confidentiality application filed together with the document.

## Key holding

Only R 262A RoP allows the Court to restrict the opposing party's and its representatives' use of confidential information. A request under R 262.2 RoP concerns future access by the public, is generally not decided until a member of the public lodges a reasoned request under R 262.1(b) RoP, and gives no provisional protection against the other party. Absent a simultaneous R 262A application, or a statement that the information is covered by an earlier R 262A order, the Court will not treat a document as confidential vis-à-vis the other party. It will routinely change an HC-coded upload to M (mutual), because there is no legal basis for the HC code in that situation.

## Questions decided

1. Does a R 262.2 RoP request protect information against disclosure by the opposing party?
2. When does the Court decide a R 262.2 RoP request to keep information from the public?
3. When must a R 262A RoP confidentiality application be made?
4. May a party upload evidence under the HC code without a R 262A application?

## Case details

- Court: Court of Appeal of the Unified Patent Court, Panel 2
- Panel: Rian Kalden (presiding judge and legally qualified judge); Ingeborg Simonsson (legally qualified judge and judge-rapporteur); Patricia Rombach (legally qualified judge); Anna Hedberg (technically qualified judge); Jeroen Meewisse (technically qualified judge)
- Date: 26-01-2026
- Case number(s): UPC CoA 917/2025, UPC CFI 697/2025
- Parties: Appellants: Merz Pharmaceuticals LLC, Merz Therapeutics GmbH and Merz Pharma France (applicants at first instance); Respondent: Viatris Santé (defendant at first instance)
- Language of the proceedings: English
- Outcome: The Court will not at this stage issue a decision on Merz's request that Exhibit 823 be kept confidential and not made accessible to the public under Art 58 UPCA and R 262.2 RoP.

## How to cite

Court of Appeal, Merz Pharmaceuticals LLC and others v Viatris Santé, UPC CoA 917/2025, Order of 26 January 2026 (OSCOLA)

## Full summary

Read the full analyses for free — create a free account: https://pitch.law/academy/upc-court-of-appeal/upc-coa-917-2025-2026-01-26

Topics: [Confidentiality and access to the file](https://pitch.law/academy/upc-court-of-appeal/topics/confidentiality-and-access), [Procedure](https://pitch.law/academy/upc-court-of-appeal/topics/procedure)

## In the same case

- [Merz Pharmaceuticals LLC and others v Viatris Santé, UPC CoA 917/2025, 27-04-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-917-2025-2026-04-27): The Court of Appeal set aside the Paris Local Division's refusal for delay and granted Merz a provisional injunction and delivery-up against Viatris Santé's generic fampridine in France until the SPC expires on 25 July 2026.

## More on confidentiality and access to the file

- [PAUSTIAN & PARTNER Patentanwälte mbB v NUC Electronics Europe GmbH and others, UPC CoA 163/2026, 11-11-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-163-2026-2026-11-11): The Court of Appeal granted a patent law firm access to the statements of appeal and statements of grounds of appeal in three closed appeals concerning EP 2 028 981.
- [The Walt Disney Company and others v InterDigital VC Holdings, Inc., UPC CoA 133/2026, 05-11-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-133-2026-2026-11-05): A request under R 262A RoP to stop the other party from accessing or using confidential information cannot be made for the first time on appeal for material already filed at first instance.
- [Netflix Services Germany GmbH and others v DivX, LLC, UPC CoA 176/2026, 02-11-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-176-2026-2026-11-02): The Court of Appeal refused Netflix's request for suspensive effect against the Munich Local Division's infringement decision in favour of DivX, even though the EPO Opposition Division revoked the patent after that decision.
- [Surf Loch LLC v American Wave Machines, Inc. and others, UPC CoA 92/2026, 04-09-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-92-2026-2026-09-04): The Court of Appeal refused a third party's request under R 262.1(b) RoP for access to the written pleadings and evidence in a pending appeal.
- [Fives ECL v REEL GmbH, UPC CoA 42/2026, 16-07-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-42-2026-2026-07-16): The Court of Appeal held that a former employee of a party may be admitted to a confidentiality club only on condition that confidential information reaches them after they have signed a penalty-backed confidentiality agreement with that party.
